Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A2 and secretory phospholipase A2 in patients with newly diagnosed type 2 diabetes

about

Lipoprotein-associated phospholipase A2 activity in obese adolescents with and without type 2 diabetes.

P2860

Q47611058-167B519A-B8C6-4A97-92E3-FA868D713013

P2860

Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A2 and secretory phospholipase A2 in patients with newly diagnosed type 2 diabetes

Item

http://www.wikidata.org/entity/Q37431606

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Effect of intensive insulin tr ...... ewly diagnosed type 2 diabetes

@en

Effect of intensive insulin tr ...... wly diagnosed type 2 diabetes.

@nl

type

Item

label

Effect of intensive insulin tr ...... ewly diagnosed type 2 diabetes

@en

Effect of intensive insulin tr ...... wly diagnosed type 2 diabetes.

@nl

prefLabel

Effect of intensive insulin tr ...... ewly diagnosed type 2 diabetes

@en

Effect of intensive insulin tr ...... wly diagnosed type 2 diabetes.

@nl

P1476

Effect of intensive insulin tr ...... ewly diagnosed type 2 diabetes

@en

P2093

Jv-Ying Tang

http://www.w3.org/2001/XMLSchema#string

Li Yan

http://www.w3.org/2001/XMLSchema#string

Li-Fang Mai

http://www.w3.org/2001/XMLSchema#string

Meng Ren

http://www.w3.org/2001/XMLSchema#string

Ming-Tong Xu

http://www.w3.org/2001/XMLSchema#string

Xiao-Yi Wang

http://www.w3.org/2001/XMLSchema#string

Xiu-Hong Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development

Type IB secretory phospholipase A2 is contained in insulin secretory granules of pancreatic islet beta-cells and is co-secreted with insulin from glucose-stimulated islets

10-year follow-up of intensive glucose control in type 2 diabetes

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

Standards of medical care in diabetes--2013

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies.

Inhibition of lipoprotein-associated phospholipase A2 ameliorates inflammation and decreases atherosclerotic plaque formation in ApoE-deficient mice.

Lipoprotein-associated and secreted phospholipases A₂ in cardiovascular disease: roles as biological effectors and biomarkers.

Increased serum level of Lp-PLA2 is independently associated with the severity of coronary artery diseases: a cross-sectional study of Chinese population

Targeting curcusomes to inflammatory dendritic cells inhibits NF-κB and improves insulin resistance in obese mice

P2888

s12944-016-0368-3

P304

203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12944-016-0368-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1014538096

http://www.w3.org/2001/XMLSchema#string

P698

27881128

http://www.w3.org/2001/XMLSchema#string

P921

lipoprotein

type-2 diabetes

P932

5120429

http://www.w3.org/2001/XMLSchema#string

Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A2 and secretory phospholipase A2 in patients with newly diagnosed type 2 diabetes

about

P2860

P2860

Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A2 and secretory phospholipase A2 in patients with newly diagnosed type 2 diabetes

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P932